Pathobiology of cardiovascular diseases: an update

Cardiovascular Pathology

Volumn 42, Issue , 2019, Pages 44-53

  Buja, L Maximilian ^a,b   Ottaviani, Giulia ^a,c   Mitchell, Richard N ^d  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b TEXAS HEART INSTITUTE   (United States)

^c UNIVERSITY OF MILAN   (Italy)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Autopsy; Cardiovascular disease; Endomyocardial biopsy; Pathobiology; Pathology

Indexed keywords

BLOOD VESSEL; CARDIAC MUSCLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; HUMAN; MORTALITY; PATHOLOGY; PROGNOSIS; RISK FACTOR;

BLOOD VESSELS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; HUMANS; MYOCARDIUM; PROGNOSIS; RISK FACTORS;

EID: 85067920815     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2019.06.002     Document Type: Review

References (189)

1. Seidman, M.A., Consensus documents — past, present, and future. Cardiovasc Pathol 36 (2018), 42–43, 10.1016/j.carpath.2018.06.003.
2. Buja, L., Ottaviani, G., Mitchell, R., Pathobiology of cardiovascular diseases: an update. Cardiovasc Pathol, 2019 in press.
3. Buja, L.M., Cardiovascular pathology: looking back on the first 25 years and forward into the future. Cardiovasc Pathol 25 (2016), 1–2, 10.1016/j.carpath.2015.11.002.
4. Saffitz, J.E., Corradi, D., The electrical heart: 25 years of discovery in cardiac electrophysiology, arrhythmias and sudden death. Cardiovasc Pathol 25 (2016), 149–157, 10.1016/j.carpath.2015.11.005.
5. Buja, L.M., Vander Heide, R.S., Pathobiology of ischemic heart disease: past, present and future. Cardiovasc Pathol 25 (2016), 214–220, 10.1016/j.carpath.2016.01.007.
6. Schoen, F.J., Gotlieb, A.I., Heart valve health, disease, replacement, and repair: a 25-year cardiovascular pathology perspective. Cardiovasc Pathol 25 (2016), 341–352, 10.1016/j.carpath.2016.05.002.
7. Ladich, E., Yahagi, K., Romero, M.E., Virmani, R., Vascular diseases: aortitis, aortic aneurysms, and vascular calcification. Cardiovasc Pathol 25 (2016), 432–441, 10.1016/j.carpath.2016.07.002.
8. Ottaviani, G., Buja, L.M., Anatomopathological changes of the cardiac conduction system in sudden cardiac death, particularly in infants: advances over the last 25 years. Cardiovasc Pathol 25 (2016), 489–499, 10.1016/j.carpath.2016.08.005.
9. Halushka, M.K., Mitchell, R.N., Padera, R.F., Heart failure therapies: new strategies for old treatments and new treatments for old strategies. Cardiovasc Pathol 25 (2016), 503–511, 10.1016/j.carpath.2016.08.008.
10. Buja, L.M., Butany, J., Cardiovascular pathology. 4th ed., 2016, Elsevier, New York.
11. Hutchins, G.M., Anaya, O.A., Measurements of cardiac size, chamber volumes and valve orifices at autopsy. Johns Hopkins Med J 133 (1973), 96–106.
12. Hutchins, G.M., Bulkley, B.H., Moore, G.W., Piasio, M.A., Lohr, F.T., Shape of the human cardiac ventricles. Am J Cardiol 41 (1978), 646–654.
13. MacIver, D.H., Stephenson, R.S., Jensen, B., Agger, P., Sánchez-Quintana, D., Jarvis, J.C., et al. The end of the unique myocardial band: part I. Anatomical considerations. Eur J Cardiothorac Surg 53 (2018), 112–119, 10.1093/ejcts/ezx290.
14. MacIver, D.H., Partridge, J.B., Agger, P., Stephenson, R.S., Boukens, B.J.D., Omann, C., et al. The end of the unique myocardial band: part II. Clinical and functional considerations. Eur J Cardiothorac Surg 53 (2018), 120–128, 10.1093/ejcts/ezx335.
15. Buckberg, G.D., Nanda, N.C., Nguyen, C., Kocica, M.J., What is the heart? Anatomy, function, pathophysiology, and misconceptions. J Cardiovasc Dev Dis, 5, 2018, 10.3390/jcdd5020033.
16. Sanz, J., Sánchez-Quintana, D., Bossone, E., Bogaard, H.J., Naeije, R., Anatomy, function, and dysfunction of the right ventricle. JACC State-of-the-Art Review. J Am Coll Cardiol 73 (2019), 1463–1482, 10.1016/j.jacc.2018.12.076.
17. Thomas, L., Marwick, T.H., Popescu, B.A., Donal, E., Badano, L.P., Left atrial structure and function, and left ventricular diastolic dysfunction. JACC state-of-the-art review. J Am Coll Cardiol 73 (2019), 1961–1977, 10.1016/j.jacc.2019.01.059.
18. Carbone, A., D'Andrea, A., Riegler, L., Scarafile, R., Pezzullo, E., Martone, F., et al. Cardiac damage in athlete's heart: when the “supernormal” heart fails!. World J Cardiol 9 (2017), 470–480, 10.4330/wjc.v9.i6.470.
19. Regev, A., Teichmann, S.A., Lander, E.S., Amit, I., Benoist, C., Birney, E., et al. The human cell atlas. Elife, 6, 2017, 10.7554/eLife.27041.
20. Plasschaert, L.W., Žilionis, R., Choo-Wing, R., Savova, V., Knehr, J., Roma, G., et al. A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte. Nature 560 (2018), 377–381, 10.1038/s41586-018-0394-6.
21. MacParland, S.A., Liu, J.C., Ma, X.-Z., Innes, B.T., Bartczak, A.M., Gage, B.K., et al. Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations. Nat Commun, 9, 2018, 4383, 10.1038/s41467-018-06318-7.
22. Buja, L.M., Barth, R.F., Krueger, G.R., Brodsky, S.V., Hunter, R.L., The importance of the autopsy in medicine: perspectives of pathology colleagues. Acad Pathol, 6, 2019, 2374289519834041, 10.1177/2374289519834041.
23. Hooper, J.E., Williamson, A.K., (eds.) Autopsy in the 21st century, 2019, Springer International Publishing AG, Cham, Switzerland, 10.1007/978-3-319-98373-8.
24. Tester, D.J., Ackerman, M.J., The role of molecular autopsy in unexplained sudden cardiac death. Curr Opin Cardiol 21 (2006), 166–172.
25. Tang, Y., Stahl-Herz, J., Sampson, B.A., Molecular diagnostics of cardiovascular diseases in sudden unexplained death. Cardiovasc Pathol 23 (2014), 1–4.
26. Iddawela, M., Rueda, O.M., Klarqvist, M., Graf, S., Earl, H.M., Caldas, C., Reliable gene expression profiling of formalin-fixed paraffin-embedded breast cancer tissue (FFPE) using cDNA-mediated annealing, extension, selection, and ligation whole-genome (DASL WG) assay. BMC Med Genomics, 9, 2016, 54, 10.1186/s12920-016-0215-4.
27. Baudhuin, L.M., Leduc, C., Train, L.J., Avula, R., Kluge, M.L., Kotzer, K.E., et al. Technical advances for the clinical genomic evaluation of sudden cardiac death: verification of next-generation sequencing panels for hereditary cardiovascular conditions using formalin-fixed paraffin-embedded tissues and dried blood spots. Circ Cardiovasc Genet, 10, 2017, 10.1161/CIRCGENETICS.117.001844.
28. Thiene, G., Saffitz, J.E., Autopsy as a source of discovery in cardiovascular medicine: Then and now. Circulation 137 (2018), 2683–2685, 10.1161/CIRCULATIONAHA.118.033234.
29. Goldman, L., Autopsy 2018: still necessary, even if occasionally not sufficient. Circulation 137 (2018), 2686–2688, 10.1161/CIRCULATIONAHA.118.033236.
30. Tseng, Z.H., Olgin, J.E., Vittinghoff, E., Ursell, P.C., Kim, A.S., Sporer, K., et al. Prospective countywide surveillance and autopsy characterization of sudden cardiac death: POST SCD Study. Circulation 137 (2018), 2689–2700, 10.1161/CIRCULATIONAHA.117.033427.
31. Myerburg, R.J., Cardiac and noncardiac causes of apparent sudden arrhythmic deaths: shadows in a spectrum. Circulation 137 (2018), 2701–2704, 10.1161/CIRCULATIONAHA.118.034594.
32. Shanks, G.W., Tester, D.J., Ackerman, J.P., Simpson, M.A., Behr, E.R., White, S.M., et al. Importance of variant interpretation in whole-exome molecular autopsy: population-based case series. Circulation 137 (2018), 2705–2715, 10.1161/CIRCULATIONAHA.117.031053.
33. Junttila, M.J., Holmström, L., Pylkäs, K., Mantere, T., Kaikkonen, K., Porvari, K., et al. Primary myocardial fibrosis as an alternative phenotype pathway of inherited cardiac structural disorders. Circulation 137 (2018), 2716–2726, 10.1161/CIRCULATIONAHA.117.032175.
34. Judge, D.P., Brown, E.E., Bringing autopsies into the molecular genetic era. Circulation 137 (2018), 2727–2729, 10.1161/CIRCULATIONAHA.118.033235.
35. Lacour, P., Buschmann, C., Storm, C., Nee, J., Parwani, A.S., Huemer, M., et al. Cardiac implantable electronic device interrogation at forensic autopsy: an underestimated resource?. Circulation 137 (2018), 2730–2740, 10.1161/CIRCULATIONAHA.117.032367.
36. Herrington, D.M., Mao, C., Parker, S.J., Fu, Z., Yu, G., Chen, L., et al. Proteomic architecture of human coronary and aortic atherosclerosis. Circulation 137 (2018), 2741–2756, 10.1161/CIRCULATIONAHA.118.034365.
37. Sklar, J., The clinical autopsy and genetic testing. Am J Pathol, 189, 2019 in press.
38. Sekiguchi, M., Konno, S., Histopathological differentiation employing endomyocardial biopsy in the clinical assessment of primary myocardial disease. Jpn Heart J 10 (1969), 30–46.
39. Caves, P.K., Stinson, E.B., Billingham, M., Shumway, N.E., Percutaneous transvenous endomyocardial biopsy in human heart recipients. Experience with a new technique. Ann Thorac Surg 16 (1973), 325–336.
40. Pereira, N.L., Grogan, M., Dec, G.W., Spectrum of restrictive and infiltrative cardiomyopathies: part 1 of a 2-part series. J Am Coll Cardiol 71 (2018), 1130–1148, 10.1016/j.jacc.2018.01.016.
41. Pereira, N.L., Grogan, M., Dec, G.W., Spectrum of restrictive and infiltrative cardiomyopathies: part 2 of a 2-part series. J Am Coll Cardiol 71 (2018), 1149–1166, 10.1016/j.jacc.2018.01.017.
42. Kransdorf, E.P., Kobashigawa, J.A., Novel molecular approaches to the detection of heart transplant rejection. Per Med 14 (2017), 293–297, 10.2217/pme-2017-0024.
43. Leone, O., Veinot, J.P., Angelini, A., Baandrup, U.T., Basso, C., Berry, G., et al. 2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol 21 (2012), 245–274, 10.1016/j.carpath.2011.10.001.
44. Thiene, G., Bruneval, P., Veinot, J., Leone, O., Diagnostic use of the endomyocardial biopsy: a consensus statement. Virchows Arch 463 (2013), 1–5, 10.1007/s00428-013-1430-4.
45. Basso, C., Calabrese, F., Angelini, A., Carturan, E., Thiene, G., Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease. Heart Fail Rev 18 (2013), 673–681, 10.1007/s10741-012-9355-6.
46. Pollack, A., Kontorovich, A.R., Fuster, V., Dec, G.W., Viral myocarditis — diagnosis, treatment options and current controversies. Nat Rev Cardiol 12 (2015), 670–680, 10.1038/nrcardio.2015.108.
47. Nair, V., Belanger, E.C., Veinot, J.P., Lysosomal storage disorders affecting the heart: a review. Cardiovasc Pathol 39 (2019), 12–24, 10.1016/j.carpath.2018.11.002.
48. Stone, J.R., Novel prognostic tissue markers in congestive heart failure. Cardiovasc Pathol 24 (2015), 65–70, 10.1016/j.carpath.2014.07.010.
49. Raikhelkar, J., Uriel, N., Immune checkpoint inhibitor myocarditis. Curr Opin Cardiol 34 (2019), 303–306, 10.1097/HCO.0000000000000622.
50. Cooper, L.T., Baughman, K.L., Feldman, A.M., Frustaci, A., Jessup, M., Kuhl, U., et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 116 (2007), 2216–2233, 10.1161/CIRCULATIONAHA.107.186093.
51. Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34:2636–48, 2648a-2648d. doi: https://doi.org/10.1093/eurheartj/eht210.
52. Vaidya, V.R., Abudan, A.A., Vasudevan, K., Shantha, G., Cooper, L.T., Kapa, S., et al. The efficacy and safety of electroanatomic mapping-guided endomyocardial biopsy: a systematic review. J Interv Card Electrophysiol, 2018, 10.1007/s10840-018-0410-7.
53. Yilmaz, A., Kindermann, I., Kindermann, M., Mahfoud, F., Ukena, C., Athanasiadis, A., et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation 122 (2010), 900–909, 10.1161/CIRCULATIONAHA.109.924167.
54. Stone, J.R., Bruneval, P., Angelini, A., Bartoloni, G., Basso, C., Batoroeva, L., et al. Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology: I. Inflammatory diseases. Cardiovasc Pathol 24 (2015), 267–278, 10.1016/j.carpath.2015.05.001.
55. Halushka, M.K., Angelini, A., Bartoloni, G., Basso, C., Batoroeva, L., Bruneval, P., et al. Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology: II. Noninflammatory degenerative diseases — nomenclature and diagnostic criteria. Cardiovasc Pathol 25 (2016), 247–257, 10.1016/j.carpath.2016.03.002.
56. Frederick, J.R., Woo, Y.J., Thoracoabdominal aortic aneurysm. Ann Cardiothorac Surg 1 (2012), 277–285, 10.3978/j.issn.2225-319X.2012.09.01.
57. Toghill, B.J., Saratzis, A., Bown, M.J., Abdominal aortic aneurysm — an independent disease to atherosclerosis?. Cardiovasc Pathol 27 (2017), 71–75, 10.1016/j.carpath.2017.01.008.
58. Golledge, J., Abdominal aortic aneurysm: update on pathogenesis and medical treatments. Nat Rev Cardiol 16 (2019), 225–242, 10.1038/s41569-018-0114-9.
59. Pinard, A., Jones, G.T., Milewicz, D.M., Genetics of thoracic and abdominal aortic diseases. Circ Res 124 (2019), 588–606, 10.1161/CIRCRESAHA.118.312436.
60. Niwa, K., Landmark lecture: Perloff lecture: tribute to Professor Joseph Kayle Perloff and lessons learned from him: aortopathy in adults with CHD. Cardiol Young 27 (2017), 1959–1965, 10.1017/S1047951117002116.
61. Fabian, O., Gebauer, R., Koblizek, M., Hornofova, L., Janousek, J., Histopathological evidence of aortopathy in newborns and infants with tetralogy of Fallot at the time of the surgical repair. Cardiovasc Pathol 40 (2019), 59–64, 10.1016/j.carpath.2019.02.004.
62. Furie, M.B., Mitchell, R.N., Plaque attack: one hundred years of atherosclerosis in The American Journal of Pathology. Am J Pathol 180 (2012), 2184–2187, 10.1016/j.ajpath.2012.04.003.
63. Hort, W., History of cardiovascular pathology. Z Kardiol, 91, 2002, 10.1007/s00392-002-1404-z Suppl 4:20–4.
64. Mayerl, C., Lukasser, M., Sedivy, R., Niederegger, H., Seiler, R., Wick, G., Atherosclerosis research from past to present — on the track of two pathologists with opposing views, Carl von Rokitansky and Rudolf Virchow. Virchows Arch 449 (2006), 96–103, 10.1007/s00428-006-0176-7.
65. Newby, A.C., An overview of the vascular response to injury: a tribute to the late Russell Ross. Toxicol Lett 112–113 (2000), 519–529.
66. Gotlieb, A.I., Atherosclerosis and acute coronary syndromes. Cardiovasc Pathol 14 (2005), 181–184, 10.1016/j.carpath.2005.03.007.
67. Gimbrone, M.A., García-Cardeña, G., Vascular endothelium, hemodynamics, and the pathobiology of atherosclerosis. Cardiovasc Pathol 22 (2013), 9–15, 10.1016/j.carpath.2012.06.006.
68. Gimbrone, M.A., García-Cardeña, G., Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res 118 (2016), 620–636, 10.1161/CIRCRESAHA.115.306301.
69. Wong, B.W., Meredith, A., Lin, D., McManus, B.M., The biological role of inflammation in atherosclerosis. Can J Cardiol 28 (2012), 631–641, 10.1016/j.cjca.2012.06.023.
70. Zhong, S., Li, L., Shen, X., Li, Q., Xu, W., Wang, X., et al. An update on lipid oxidation and inflammation in cardiovascular diseases. Free Radic Biol Med, 2019, 10.1016/j.freeradbiomed.2019.03.036.
71. Zhao, T.X., Mallat, Z., Targeting the immune system in atherosclerosis. JACC state-of-the-art review. J Am Coll Cardiol 73 (2019), 1691–1706, 10.1016/j.jacc.2018.12.083.
72. Libby, P., Everett, B.M., Novel antiatherosclerotic therapies. Arterioscler Thromb Vasc Biol 39 (2019), 538–545, 10.1161/ATVBAHA.118.310958.
73. Schwartz, S.M., Virmani, R., Majesky, M.W., An update on clonality: what smooth muscle cell type makes up the atherosclerotic plaque?. F1000Research, 7, 2018, 10.12688/f1000research.15994.1.
74. Jaiswal, S., Natarajan, P., Silver, A.J., Gibson, C.J., Bick, A.G., Shvartz, E., et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med 377 (2017), 111–121, 10.1056/NEJMoa1701719.
75. Fuster, J.J., Walsh, K., Somatic mutations and clonal hematopoiesis: unexpected potential new drivers of age-related cardiovascular disease. Circ Res 122 (2018), 523–532, 10.1161/CIRCRESAHA.117.312115.
76. Libby, P., Loscalzo, J., Ridker, P.M., Farkouh, M.E., Hsue, P.Y., Fuster, V., et al. Inflammation, immunity, and infection in atherothrombosis. JACC review topic of the week. J Am Coll Cardiol 72 (2018), 2071–2081, 10.1016/j.jacc.2018.08.1043.
77. Fishbein, M.C., Fishbein, G.A., Arteriosclerosis: facts and fancy. Cardiovasc Pathol 24 (2015), 335–342, 10.1016/j.carpath.2015.07.007.
78. Buja, L.M., The pathobiology of acute coronary syndromes: clinical implications and central role of the mitochondria. Texas Hear Inst J 40 (2013), 221–228.
79. Libby, P., Mechanisms of acute coronary syndromes. N Engl J Med 369 (2013), 883–884, 10.1056/NEJMc1307806.
80. Weisse, A.B., The elusive clot: the controversy over coronary thrombosis in myocardial infarction. J Hist Med Allied Sci 61 (2006), 66–78, 10.1093/jhmas/jrj003.
81. Otsuka, F., Finn, A.V., Yazdani, S.K., Nakano, M., Kolodgie, F.D., Virmani, R., The importance of the endothelium in atherothrombosis and coronary stenting. Nat Rev Cardiol 9 (2012), 439–453, 10.1038/nrcardio.2012.64.
82. Nakano, M., Otsuka, F., Yahagi, K., Sakakura, K., Kutys, R., Ladich, E.R., et al. Human autopsy study of drug-eluting stents restenosis: histomorphological predictors and neointimal characteristics. Eur Heart J 34 (2013), 3304–3313, 10.1093/eurheartj/eht241.
83. Mori, H., Torii, S., Harari, E., Jinnouchi, H., Brauman, R., Smith, S., et al. Pathological mechanisms of left main stent failure. Int J Cardiol 263 (2018), 9–16, 10.1016/j.ijcard.2018.02.119.
84. Jinnouchi, H., Torii, S., Sakamoto, A., Kolodgie, F.D., Virmani, R., Finn, A.V., Fully bioresorbable vascular scaffolds: lessons learned and future directions. Nat Rev Cardiol 16 (2019), 286–304, 10.1038/s41569-018-0124-7.
85. Buja, L.M., Vascular responses to percutaneous coronary intervention with bare-metal stents and drug-eluting stents. a perspective based on insights from pathological and clinical studies. J Am Coll Cardiol 57 (2011), 1323–1326, 10.1016/j.jacc.2010.11.033.
86. Shah, S.M., Pfau, S.E., Coronary physiology in the cardiac catheterization laboratory. J Clin Med, 8, 2019, 10.3390/jcm8020255.
87. Dulohery, K., Papavdi, A., Michalodimitrakis, M., Kranioti, E.F., Evaluation of coronary stenosis with the aid of quantitative image analysis in histological cross sections. J Forensic Leg Med 19 (2012), 485–489, 10.1016/j.jflm.2012.04.024.
88. Barth, R.F., Kellough, D.A., Allenby, P., Blower, L.E., Hammond, S.H., Allenby, G.M., et al. Assessment of atherosclerotic luminal narrowing of coronary arteries based on morphometrically generated visual guides. Cardiovasc Pathol 29 (2017), 53–60, 10.1016/j.carpath.2017.05.005.
89. Precht, H., Broersen, A., Kitslaar, P.H., Dijkstra, J., Gerke, O., Thygesen, J., et al. A novel alignment procedure to assess calcified coronary plaques in histopathology, post-mortem computed tomography angiography and optical coherence tomography. Cardiovasc Pathol 39 (2019), 25–29, 10.1016/j.carpath.2018.11.005.
90. Garcia-Garcia, H.M., Gonzalo, N., Regar, E., Serruys, P.W., Virtual histology and optical coherence tomography: from research to a broad clinical application. Heart 95 (2009), 1362–1374, 10.1136/hrt.2008.151159.
91. Matthews, S.D., Frishman, W.H., A review of the clinical utility of intravascular ultrasound and optical coherence tomography in the assessment and treatment of coronary artery disease. Cardiol Rev 25 (2017), 68–76, 10.1097/CRD.0000000000000128.
92. Maehara, A., Matsumura, M., Ali, Z.A., Mintz, G.S., Stone, G.W., IVUS-guided versus OCT-guided coronary stent implantation: a critical appraisal. JACC Cardiovasc Imaging 10 (2017), 1487–1503, 10.1016/j.jcmg.2017.09.008.
93. Stone, G.W., Mintz, G.S., Virmani, R., Vulnerable plaques, vulnerable patients, and intravascular imaging. J Am Coll Cardiol 72 (2018), 2022–2026, 10.1016/j.jacc.2018.09.010.
94. Aboshady, I., Cody, D.D., Johnson, E.M., Gahremanpour, A., Vela, D., Khalil, K.G., et al. Flat-panel versus 64-channel computed tomography for in vivo quantitative characterization of aortic atherosclerotic plaques. Int J Cardiol 156 (2012), 295–302, 10.1016/j.ijcard.2010.11.011.
95. Phipps, J.E., Hoyt, T., Vela, D., Wang, T., Michalek, J.E., Buja, L.M., et al. Diagnosis of thin-capped fibroatheromas in intravascular optical coherence tomography images: effects of light scattering. Circ Cardiovasc Interv, 9, 2016, 10.1161/CIRCINTERVENTIONS.115.003163.
96. Jo, J.A., Park, J., Pande, P., Shrestha, S., Serafino, M.J., Rico Jimenez J de J, et al., Simultaneous morphological and biochemical endogenous optical imaging of atherosclerosis. Eur Heart J Cardiovasc Imaging 16 (2015), 910–918, 10.1093/ehjci/jev018.
97. Phipps, J.E., Vela, D., Hoyt, T., Halaney, D.L., Mancuso, J.J., Buja, L.M., et al. Macrophages and intravascular OCT bright spots. a quantitative study. JACC Cardiovasc Imaging 8 (2015), 63–72, 10.1016/j.jcmg.2014.07.027.
98. Thygesen, K., Alpert, J.S., White, H.D., Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Jaffe AS, Apple FS, et al., Universal definition of myocardial infarction. Circulation 116 (2007), 2634–2653, 10.1161/CIRCULATIONAHA.107.187397.
99. Thygesen, K., Alpert, J.S., Jaffe, A.S., Chaitman, B.R., Bax, J.J., Morrow, D.A., et al. Fourth universal definition of myocardial infarction (2018). Circulation 138 (2018), e618–e651, 10.1161/CIR.0000000000000617.
100. Sandoval, Y., Jaffe, A.S., Type 2 myocardial infarction. JACC review topic of the week. J Am Coll Cardiol 73 (2019), 1846–1860, 10.1016/j.jacc.2019.02.018.
101. McCarthy C, Murphy S, Cohen JA, Rehman S, Jones-O'Connor M, Olshan DS, et al. Misclassification of myocardial injury as myocardial infarction: implications for assessing outcomes in value-based programs. JAMA Cardiol 2019:Epub ahead of print. doi:10.1001/jamacardio.2019.0716.
102. Benjamin, E.J., Muntner, P., Alonso, A., Bittencourt, M.S., Callaway, C.W., Carson, A.P., et al. Heart disease and stroke statistics — 2019 update: a report from the American Heart Association. Circulation 139 (2019), e56–528, 10.1161/CIR.0000000000000659.
103. Ottaviani, G., Crib death — sudden infant death syndrome (SIDS). Sudden infant and perinatal unexplained death: the pathologist's viewpoint. 2nd ed. 2014, Springer International Publishing AG, Heidelberg, Germany, 10.1007/978-3-319-08347-6.
104. Ottaviani, G., Buja, L.M., Update on congenital heart disease and sudden infant/perinatal death: from history to future trends. J Clin Pathol 70 (2017), 555–562, 10.1136/jclinpath-2017-204326.
105. Ottaviani, G., Defining sudden infant death and sudden intrauterine unexpected death syndromes with regard to anatomo-pathological examination. Front Pediatr, 4, 2016, 103, 10.3389/fped.2016.00103.
106. 2-related vasoconstriction superimposed on ischemic medullary brain autonomic nuclei may contribute to sudden death. Cardiovasc Pathol 38 (2019), 42–45, 10.1016/j.carpath.2018.10.009.
107. Steinhaus, D.A., Vittinghoff, E., Moffatt, E., Hart, A.P., Ursell, P., Tseng, Z.H., Characteristics of sudden arrhythmic death in a diverse, urban community. Am Heart J 163 (2012), 125–131, 10.1016/j.ahj.2011.09.016.
108. Myerburg, R.J., Sudden cardiac death. interface between pathophysiology and epidemiology. Card Electrophysiol Clin 9 (2017), 515–524, 10.1016/j.ccep.2017.07.003.
109. Basso, C., Burke, M., Fornes, P., Gallagher, P.J., de Gouveia, R.H., Sheppard, M., et al. Guidelines for autopsy investigation of sudden cardiac death. Virchows Arch 452 (2008), 11–18, 10.1007/s00428-007-0505-5.
110. Basso, C., Aguilera, B., Banner, J., Cohle, S., D'Amati, G., de Gouveia, R.H., et al. Guidelines for autopsy investigation of sudden cardiac death: 2017 update from the Association for European Cardiovascular Pathology. Virchows Arch 471 (2017), 691–705, 10.1007/s00428-017-2221-0.
111. Buja, L.M., Willerson, J.T., Relationship of ischemic heart disease to sudden death. J Forensic Sci 36 (1991), 25–33.
112. Prakash, S.K., Haden-Pinneri, K., Milewicz, D.M., Susceptibility to acute thoracic aortic dissections in patients dying outside the hospital: an autopsy study. Am Heart J 162 (2011), 474–479, 10.1016/j.ahj.2011.06.020.
113. Noseworthy, P.A., Newton-Cheh, C., Genetic determinants of sudden cardiac death. Circulation 118 (2008), 1854–1863, 10.1161/CIRCULATIONAHA.108.783654.
114. Schwartz, P.J., Crotti, L., George, A.L., Modifier genes for sudden cardiac death. Eur Heart J 39 (2018), 3925–3931, 10.1093/eurheartj/ehy502.
115. Haider, A.W., Larson, M.G., Benjamin, E.J., Levy, D., Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 32 (1998), 1454–1459.
116. Reinier, K., Dervan, C., Singh, T., Uy-Evanado, A., Lai, S., Gunson, K., et al. Increased left ventricular mass and decreased left ventricular systolic function have independent pathways to ventricular arrhythmogenesis in coronary artery disease. Hear Rhythm 8 (2011), 1177–1182, 10.1016/j.hrthm.2011.02.037.
117. Shenasa, M., Shenasa, H., Hypertension, left ventricular hypertrophy, and sudden cardiac death. Int J Cardiol 237 (2017), 60–63, 10.1016/j.ijcard.2017.03.002.
118. van der Harst, P., van Setten, J., Verweij, N., Vogler, G., Franke, L., Maurano, M.T., et al. 52 genetic loci influencing myocardial mass. J Am Coll Cardiol 68 (2016), 1435–1448, 10.1016/j.jacc.2016.07.729.
119. Ottaviani G, Buja LM. Congenital heart disease. In: Buja L, Butany J, editors. Cardiovasc. Pathol. 4th ed., New York: Elsevier; 2016, p. 611–47. doi: https://doi.org/10.1016/B978-0-12-420219-1.00014-8.
120. Rickert-Sperling, S., Kelly, R.G., Driscoll, D.J., (eds.) Congenital heart diseases: the broken heart, 2016, Springer Verlag, Vienna, 10.1007/978-3-7091-1883-2.
121. Nemer, M., Genetic insights into normal and abnormal heart development. Cardiovasc Pathol 17 (2008), 48–54, 10.1016/j.carpath.2007.06.005.
122. Cui, M., Wang, Z., Bassel-Duby, R., Olson, E.N., Genetic and epigenetic regulation of cardiomyocytes in development, regeneration and disease. Development, 145, 2018, 10.1242/dev.171983.
123. Wang, J., Liu, S., Heallen, T., Martin, J.F., The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration. Nat Rev Cardiol 15 (2018), 672–684, 10.1038/s41569-018-0063-3.
124. Schoen, F.J., Introduction to congenital heart disease articles in cardiovascular pathology. Cardiovasc Pathol 19 (2010), 257–258, 10.1016/j.carpath.2010.04.008.
125. Thiene, G., Frescura, C., Anatomical and pathophysiological classification of congenital heart disease. Cardiovasc Pathol 19 (2010), 259–274, 10.1016/j.carpath.2010.02.006.
126. Edwards, W.D., Postoperative pathology of congenital heart disease. Cardiovasc Pathol 19 (2010), 275–280, 10.1016/j.carpath.2010.02.004.
127. McManus, B., Adult congenital heart disease — challenges and opportunities for pathologists. Cardiovasc Pathol 19 (2010), 281–285, 10.1016/j.carpath.2009.10.005.
128. Schoen, F.J., Cardiac valves and valvular pathology. Cardiovasc Pathol 14 (2005), 189–194, 10.1016/j.carpath.2005.03.005.
129. Watkins, D.A., Johnson, C.O., Colquhoun, S.M., Karthikeyan, G., Beaton, A., Bukhman, G., et al. Global, regional, and national burden of rheumatic heart disease, 1990-2015. N Engl J Med 377 (2017), 713–722, 10.1056/NEJMoa1603693.
130. Arora, S., Ramm, C.J., Bahekar, A.A., Vavalle, J.P., Evaluating health of emerging economies through the eyes of heart valve disease in the transcatheter era. Glob Heart 12 (2017), 301–304, 10.1016/j.gheart.2017.01.016.
131. Yap, S.-C., Takkenberg, J.J., Witsenburg, M., Meijboom, F.J., Roos-Hesselink, J.W., Aortic stenosis at young adult age. Expert Rev Cardiovasc Ther 3 (2005), 1087–1098, 10.1586/14779072.3.6.1087.
132. Yutzey, K.E., Demer, L.L., Body, S.C., Huggins, G.S., Towler, D.A., Giachelli, C.M., et al. Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease. Arterioscler Thromb Vasc Biol 34 (2014), 2387–2393, 10.1161/ATVBAHA.114.302523.
133. Coté, N., Mahmut, A., Bosse, Y., Couture, C., Pagé, S., Trahan, S., et al. Inflammation is associated with the remodeling of calcific aortic valve disease. Inflammation 36 (2013), 573–581, 10.1007/s10753-012-9579-6.
134. Akahori, H., Tsujino, T., Masuyama, T., Ishihara, M., Mechanisms of aortic stenosis. J Cardiol 71 (2018), 215–220, 10.1016/j.jjcc.2017.11.007.
135. Wirrig, E.E., Yutzey, K.E., Transcriptional regulation of heart valve development and disease. Cardiovasc Pathol 20 (2011), 162–167, 10.1016/j.carpath.2010.06.010.
136. Grewal, N., Girdauskas, E., DeRuiter, M., Goumans, M.-J., Poelmann, R.E., Klautz, R.J.M., et al. The role of hemodynamics in bicuspid aortopathy: a histopathologic study. Cardiovasc Pathol 41 (2019), 29–37, 10.1016/j.carpath.2019.03.002.
137. Gomel, M.A., Lee, R., Grande-Allen, K.J., Comparing the role of mechanical forces in vascular and valvular calcification progression. Front Cardiovasc Med, 5, 2018, 197, 10.3389/fcvm.2018.00197.
138. Enriquez-Sarano, M., Akins, C.W., Vahanian, A., Mitral regurgitation. Lancet 373 (2009), 1382–1394, 10.1016/S0140-6736(09)60692-9.
139. Yahagi, K., Ladich, E., Kutys, R., Mori, H., Svensson, L.G., Mack, M.J., et al. Pathology of balloon-expandable transcatheter aortic valves. Catheter Cardiovasc Interv 90 (2017), 1048–1057, 10.1002/ccd.27160.
140. Fishbein, G.A., Schoen, F.J., Fishbein, M.C., Transcatheter aortic valve implantation: status and challenges. Cardiovasc Pathol 23 (2014), 65–70, 10.1016/j.carpath.2013.10.001.
141. Loeser, H., Wittersheim, M., Puetz, K., Friemann, J., Buettner, R., Fries, J.W.U., Potential complications of transcatheter aortic valve implantation (TAVI) — an autopsy perspective. Cardiovasc Pathol 22 (2013), 319–323, 10.1016/j.carpath.2013.01.006.
142. Markham, R., Kyranis, S., Aroney, N., Lau, K., Poon, K., Scalia, G., et al. Transcatheter mitral valve intervention: an emerging treatment for mitral regurgitation. Intern Med J 48 (2018), 382–390, 10.1111/imj.13750.
143. Tabata, N., Sinning, J.-M., Kaikita, K., Tsujita, K., Nickenig, G., Werner, N., Current status and future perspective of structural heart disease intervention. J Cardiol, 2019, 10.1016/j.jjcc.2019.02.022.
144. Kitkungvan, D., Nabi, F., Kim, R.J., Bonow, R.O., Khan, M.A., Xu, J., et al. Myocardial fibrosis in patients with primary mitral regurgitation with and without prolapse. J Am Coll Cardiol 72 (2018), 823–834, 10.1016/j.jacc.2018.06.048.
145. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies, Br Heart J 44 (1980), 672–673, 10.1136/hrt.44.6.672.
146. Thiene, G., Basso, C., Calabrese, F., Angelini, A., Valente, M., Twenty years of progress and beckoning frontiers in cardiovascular pathology. Cardiovasc Pathol 14 (2005), 165–169, 10.1016/j.carpath.2005.03.008.
147. Poller, W., Kühl, U., Tschoepe, C., Pauschinger, M., Fechner, H., Schultheiss, H.-P., Genome–environment interactions in the molecular pathogenesis of dilated cardiomyopathy. J Mol Med (Berl) 83 (2005), 579–586, 10.1007/s00109-005-0664-2.
148. Weintraub, R.G., Semsarian, C., Macdonald, P., Dilated cardiomyopathy. Lancet (London, England) 390 (2017), 400–414, 10.1016/S0140-6736(16)31713-5.
149. Maron, B.J., Towbin, J.A., Thiene, G., Antzelevitch, C., Corrado, D., Arnett, D., et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113 (2006), 1807–1816, 10.1161/CIRCULATIONAHA.106.174287.
150. Elliott, P., Andersson, B., Arbustini, E., Bilinska, Z., Cecchi, F., Charron, P., et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29 (2008), 270–276, 10.1093/eurheartj/ehm342.
151. Thiene, G., Corrado, D., Basso, C., Revisiting definition and classification of cardiomyopathies in the era of molecular medicine. Eur Heart J 29 (2008), 144–146, 10.1093/eurheartj/ehm585.
152. Braunwald, E., Cardiomyopathies: an overview. Circ Res 121 (2017), 711–721, 10.1161/CIRCRESAHA.117.311812.
153. Lee, T.M., Hsu, D.T., Kantor, P., Towbin, J.A., Ware, S.M., Colan, S.D., et al. Pediatric cardiomyopathies. Circ Res 121 (2017), 855–873, 10.1161/CIRCRESAHA.116.309386.
154. Jan, M.F., Tajik, A.J., Modern imaging techniques in cardiomyopathies. Circ Res 121 (2017), 874–891, 10.1161/CIRCRESAHA.117.309600.
155. McKenna, W.J., Maron, B.J., Thiene, G., Classification, epidemiology, and global burden of cardiomyopathies. Circ Res 121 (2017), 722–730, 10.1161/CIRCRESAHA.117.309711.
156. McNally, E.M., Mestroni, L., Dilated cardiomyopathy: genetic determinants and mechanisms. Circ Res 121 (2017), 731–748, 10.1161/CIRCRESAHA.116.309396.
157. Marian, A.J., Braunwald, E., Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res 121 (2017), 749–770, 10.1161/CIRCRESAHA.117.311059.
158. Nishimura, R.A., Seggewiss, H., Schaff, H.V., Hypertrophic obstructive cardiomyopathy: surgical myectomy and septal ablation. Circ Res 121 (2017), 771–783, 10.1161/CIRCRESAHA.116.309348.
159. Corrado, D., Basso, C., Judge, D.P., Arrhythmogenic cardiomyopathy. Circ Res 121 (2017), 784–802, 10.1161/CIRCRESAHA.117.309345.
160. Trachtenberg, B.H., Hare, J.M., Inflammatory cardiomyopathic syndromes. Circ Res 121 (2017), 803–818, 10.1161/CIRCRESAHA.117.310221.
161. Muchtar, E., Blauwet, L.A., Gertz, M.A., Restrictive cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res 121 (2017), 819–837, 10.1161/CIRCRESAHA.117.310982.
162. Towbin, J.A., Jefferies, J.L., Cardiomyopathies due to left ventricular noncompaction, mitochondrial and storage diseases, and inborn errors of metabolism. Circ Res 121 (2017), 838–854, 10.1161/CIRCRESAHA.117.310987.
163. Blau, H.M., Daley, G.Q., Stem cells in the treatment of disease. N Engl J Med 380 (2019), 1748–1760, 10.1056/NEJMra1716145.
164. Buja, L.M., Vela, D., Cardiomyocyte death and renewal in the normal and diseased heart. Cardiovasc Pathol 17 (2008), 349–374, 10.1016/j.carpath.2008.02.004.
165. Buja, L.M., Cardiac repair and the putative role of stem cells. J Mol Cell Cardiol 128 (2019), 96–104, 10.1016/j.yjmcc.2019.01.022.
166. Chien, K.R., Frisén, J., Fritsche-Danielson, R., Melton, D.A., Murry, C.E., Weissman, I.L., Regenerating the field of cardiovascular cell therapy. Nat Biotechnol 37 (2019), 232–237, 10.1038/s41587-019-0042-1.
167. Madonna, R., Van Laake, L.W., Botker, H.E., Davidson, S.M., De Caterina, R., Engel, F.B., et al. ESC Working Group on Cellular Biology of the Heart: position paper for cardiovascular research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure. Cardiovasc Res 115 (2019), 488–500, 10.1093/cvr/cvz010.
168. Eschenhagen, T., Bolli, R., Braun, T., Field, L.J., Fleischmann, B.K., Frisén, J., et al. Cardiomyocyte regeneration: a consensus statement. Circulation 136 (2017), 680–686, 10.1161/CIRCULATIONAHA.117.029343.
169. Barile, L., Lionetti, V., Prometheus's heart: what lies beneath. J Cell Mol Med 16 (2012), 228–236, 10.1111/j.1582-4934.2011.01487.x.
170. Franklin, S., Kimball, T., Rasmussen, T.L., Rosa-Garrido, M., Chen, H., Tran, T., et al. The chromatin-binding protein Smyd1 restricts adult mammalian heart growth. Am J Physiol Heart Circ Physiol 311 (2016), H1234–H1247, 10.1152/ajpheart.00235.2016.
171. Leach, J.P., Heallen, T., Zhang, M., Rahmani, M., Morikawa, Y., Hill, M.C., et al. Hippo pathway deficiency reverses systolic heart failure after infarction. Nature 550 (2017), 260–264, 10.1038/nature24045.
172. Vela, D., Gahremanpour, A., Buja, L.M., Method for sectioning and sampling hearts for histologic evaluation after delivery of biological agents by transendocardial injection. Cardiovasc Pathol 24 (2015), 304–309, 10.1016/j.carpath.2015.04.005.
173. Kemp CD, Conte J V. The pathophysiology of heart failure. Cardiovasc Pathol n.d.;21:365–71. doi: https://doi.org/10.1016/j.carpath.2011.11.007.
174. Fedak, P.W.M., Verma, S., Weisel, R.D., Li, R.-K., Cardiac remodeling and failure. Cardiovasc Pathol 14 (2005), 1–11, 10.1016/j.carpath.2004.12.002.
175. Fedak, P.W.M., Verma, S., Weisel, R.D., Li, R.-K., Cardiac remodeling and failure. Cardiovasc Pathol 14 (2005), 49–60, 10.1016/j.carpath.2005.01.005.
176. Ottaviani, G., Radovancevic, R., Kar, B., Gregoric, I., Buja, L.M., Pathological assessment of end-stage heart failure in explanted hearts in correlation with hemodynamics in patients undergoing orthotopic heart transplantation. Cardiovasc Pathol 24 (2015), 283–289, 10.1016/j.carpath.2015.06.002.
177. Ottaviani, G., Segura, A.M., Rajapreyar, I.N., Zhao, B., Radovancevic, R., Loyalka, P., et al. Left ventricular noncompaction cardiomyopathy in end-stage heart failure patients undergoing orthotopic heart transplantation. Cardiovasc Pathol 25 (2016), 293–299, 10.1016/j.carpath.2016.03.004.
178. Glass, C.K., Mitchell, R.N., Winning the battle, but losing the war: mechanisms and morphology of cancer-therapy-associated cardiovascular toxicity. Cardiovasc Pathol 30 (2017), 55–63, 10.1016/j.carpath.2017.06.009.
179. Odim, J., Reehal, V., Laks, H., Mehta, U., Fishbein, M.C., Surgical pathology of cardiac tumors. Two decades at an urban institution. Cardiovasc Pathol 12 (2003), 267–270.
180. North, P.E., Waner, M., Buckmiller, L., James, C.A., Mihm, M.C., Vascular tumors of infancy and childhood: beyond capillary hemangioma. Cardiovasc Pathol 15 (2006), 303–317, 10.1016/j.carpath.2006.03.001.
181. Thomas-de-Montpréville, V., Nottin, R., Dulmet, E., Serraf, A., Heart tumors in children and adults: clinicopathological study of 59 patients from a surgical center. Cardiovasc Pathol 16 (2007), 22–28, 10.1016/j.carpath.2006.05.008.
182. Coard, K.C.M., Primary tumors of the heart: experience at the University Hospital of the West Indies. Cardiovasc Pathol 16 (2007), 98–103, 10.1016/j.carpath.2006.09.006.
183. Burke, A., Virmani, R., Pediatric heart tumors. Cardiovasc Pathol 17 (2008), 193–198, 10.1016/j.carpath.2007.08.008.
184. Patel, J., Sheppard, M.N., Pathological study of primary cardiac and pericardial tumours in a specialist UK centre: surgical and autopsy series. Cardiovasc Pathol 19 (2010), 343–352, 10.1016/j.carpath.2009.07.005.
185. Strecker, T., Rösch, J., Weyand, M., Agaimy, A., Primary and metastatic cardiac tumors: imaging characteristics, surgical treatment, and histopathological spectrum: a 10-year-experience at a German heart center. Cardiovasc Pathol 21 (2012), 436–443, 10.1016/j.carpath.2011.12.004.
186. Agaimy, A., Rösch, J., Weyand, M., Strecker, T., Primary and metastatic cardiac sarcomas: a 12-year experience at a German heart center. Int J Clin Exp Pathol 5 (2012), 928–938.
187. Barreiro, M., Renilla, A., Jimenez, J.M., Martin, M., Al Musa, T., Garcia, L., et al. Primary cardiac tumors: 32 years of experience from a Spanish tertiary surgical center. Cardiovasc Pathol 22 (2013), 424–427, 10.1016/j.carpath.2013.04.006.
188. Saad, A.M., Abushouk, A.I., Al-Husseini, M.J., Salahia, S., Alrefai, A., Afifi, A.M., et al. Characteristics, survival and incidence rates and trends of primary cardiac malignancies in the United States. Cardiovasc Pathol 33 (2018), 27–31, 10.1016/j.carpath.2017.12.001.
189. Wang, J.-G., Wang, B., Hu, Y., Liu, J.-H., Liu, B., Liu, H., et al. Clinicopathologic features and outcomes of primary cardiac tumors: a 16-year-experience with 212 patients at a Chinese medical center. Cardiovasc Pathol 33 (2018), 45–54, 10.1016/j.carpath.2018.01.003.